Presentation is loading. Please wait.

Presentation is loading. Please wait.

OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.

Similar presentations


Presentation on theme: "OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and."— Presentation transcript:

1 OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading- edge peer reviewed Open Access Journals and organizes over 300 International Conferences annually all over the world. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 1000 International Societies to make healthcare information Open Access.

2 OMICS Group welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible way. OMICS Journals are poised in excellence by publishing high quality research. OMICS Group follows an Editorial Manager® System peer review process and boasts of a strong and active editorial board. Editors and reviewers are experts in their field and provide anonymous, unbiased and detailed reviews of all submissions. The journal gives the options of multiple language translations for all the articles and all archived articles are available in HTML, XML, PDF and audio formats. Also, all the published articles are archived in repositories and indexing services like DOAJ, CAS, Google Scholar, Scientific Commons, Index Copernicus, EBSCO, HINARI and GALE. For more details please visit our website: OMICS Journals are welcoming Submissions

3

4 Biography Mr. Sarfraz Ahmad is working at Aberdeen Royal Infirmary Hospital, NHS Grampian, Aberdeen, UK. He did his medical graduation (MBBS) from Nishtar Medical College Multan, Pakistan. For his work on ‘DNA vaccination for Prostate cancer’ he was awarded with PhD from National University of Ireland in He holds a prestigious clinical fellowship from Focused Ultrasound Surgery Foundation, Virgina USA. Additionally, he also had a Membership (MRCS) & a Fellowship of Royal College of Surgeons of Edinburgh in Urology (FRCS Urol). His main clinical inters include, Uro-oncology, minimal invasive/ Robotic Urology, investigating new methods for Urological cancer detection, Focused Ultrasound and cancer immunotherapy.

5 Biography He has presented his research work in numerous scientific /clinical meetings around the world. His published work is highly appreciation from experts peers and it is cited extensively in international literature. He received prestigious awards from the European Association of Urology in 2010 and from Irish Journal of Medical Science in Additionally, he received “Young Investigator award” from Focused Ultrasound Surgery Foundation, Washington, USA.

6 Main Research Interests Development of DNA vaccination for Prostate cancer Quantitative Shear Wave Elastography for prostate cancer Bladder cancer Diagnosis using Raman Spectroscopy Focused Ultrasound for bony metastases Photodynamic Diagnosis of upper and lower urinary tract transitional cell carcinoma (TCC)

7 Scientific Awards Irish journal of medical Science (IJMS) Doctors Award for best paper published from Ireland in all surgical specialities (between )

8 Scientific Awards European Association of Urology award for best paper published on fundamental research in Urological literature in 2009

9 Scientific Awards Young Investigator Travel Award, 3 rd International Symposium on Focused Ultrasound, Washington, USA The prestigious award was given for following work; “Localisation of Prostate Cancer Foci with Transrectal Quantitative Shear Wave Elastography – A Step Towards Focal Therapy for Prostate Cancer”

10 Main Publications  Significance of MUC1 in bladder cancer, S. Ahmad, TB. Lam, J. N' Dow, BJUI – Feb 2014 PMID:  Editorial – Fusion of MRI and TRUS images for targeted biopsy of prostate, S. Ahmad, J Med Diagn Meth Feb 2014  Training model for transurethral resection of prostate using human cadavers embalmed by Thiel's method, S. Ahmad, D. Byrne, G. Nabi, Journal of Endourology, Part B: Videourology, Sept 2013  Transrectal Quantitative Shear Wave Elastography in the Detection and Characterisation of Prostate Cancer, S. Ahmad, R. Cao, T. Varghese, L. Bidaut, G. Nabi, Surgical Endoscopy, Sept 2013, PMID:  Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma, O. Aboumarzouk, B. Somani, S. Ahmad, G. Nabi, N. Townell, S. G. Kata, Urology Annalas, July 2013, PMID  DNA vaccination for Prostate cancer, from preclinical to clinical trials – where we stand? S. Ahmad, P. Sweeney, G. C. O’Sullivan, M. Tangney, Genetic Vaccines and Therapy Oct. 2012, PMID:

11 Main Publications  Response of Thiel-embalmed Human Liver and Kidney to MR- guided Focused Ultrasound Surgery, I. Karakitsios, T. Saliev, H. McLeod, S. Ahmad, R. Eisma, A. Melzer, Biomed Tech (Berl), August 2012 –PMID:  An 11-year of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999–2009, Cullen IM, Manecksha RP, McCullagh E, Ahmad S, Flynn, R, McDermott TED, Murphy P, Grainger R, Fennell JP, Thornhill JA, Ir J Med Sci, June 2012 – PMID:  Oral 5 - aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma – a prospective audit, S. Ahmad, O. Aboumarzouk, B. Somani, G. Nabi, S. G. Kata, BJUI, March 2012 – PMID  Estimation of clincally significant prostate volumes by digital rectal examination - a comparative prospective study, S. Ahmad, R.P. Manecksha, I.M. Cullen, T.E.D. McDermott, R. Flynn, R. Grainger, J.A. Thornhill, Can J Urol, 2011 Dec: PMID:  A minimal invasive temporary cavernoso-saphenous shunt in the management of priapism, M. Edward, O. Aboumarzouk, S. Ahmad, G. Nabi, Minimally invasive Therapy & Allied Tech 2011 Dec. PMID:

12  Prospective randomized controlled trial comparing trigonal versus trigone-sparing intradetrusor injection of botulinum toxin A for refractory idiopathic detrusor overactivity Manecksha, R.P., Cullen, I.M., Ahmad, S., McNeill, G.J., McDermott, T.E.D., Flynn, R.J., Grainger, R., Thornhill, J.A., Eur Urol, 2011 Nov 7. PMID:  Survival after incidental prostate cancer diagnosis at transurethral resection of prostate – 10 year outcomes, S. Ahmad, F. O’Kelly, R.P. Manecksha, I.M. Cullen, R. Flynn, T.E.D. McDermott, R. Grainger, J. A. Thornhill, Ir J Med Sci, 2011 Sept. PMID:  The changing pattern of antimicrobial resistance within Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract Infections, Dublin, , Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA, BJU Int Aug 24. PMID:  Induction of effective anti-tumour responses following mucosal bacterial vector mediated DNA vaccination with an endogenous prostate cancer specific antigen, S. Ahmad, G. Casey, M. Cronin, S. Rajendran, P. Sweeney, M. Tangney, G. C. O'Sullivan, J Urol Aug; 186(2): PMID:  Case report of a symptomatic giant renal oncocytoma, S. Ahmad, R. Manecksha, B. D. Hayes, R. Grainger, Int J Surg Case Rep 2011 March, PMID Main Publications

13  Gene therapy for prostate cancer, M. Tangney, S. Ahmad, S. A. Collins, G. C. O’Sullivan, Postgrad Med May; 122(3):166-80, PMID:  Optimise electroporation mediated DNA vaccination for prostate cancer, S. Ahmad, G. Casey, P. Sweeney, M. Tangney, G. C. O'Sullivan, Genetic Vaccines and Therapy 8: Feb, PMID:  VHL genetic alteration in CCRC does not determine deregulation of HIF, CAIX, hnRNPA2/B1 and osteopontin, Nyhan MJ, EL Mashad SM, O’Donovan TB, Ahmad S, Collins C, Sweeney P, Rogers E, O'Sullivan GC, McKenna SL Anal Cell Pathol 2010 Jan 1; 33 (3): PMID:  Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth, S. Ahmad, G. Casey, P. Sweeney, M. Tangney, G. C. O'Sullivan Molecular Therapy 17, , 2009 Jun PMID:  Retroperitoneal paraganglioma, a rare but important diagnosis, S. Ahmad, C. Dewhurst, M. Sheikh, P. Sweeney, Ir J Med Sci 178 (2), , 2009 Jun PMID:

14 Medical & Surgical Urology Related Journals  Andrology & Gynecology: Current Research  Gynecology & Obstetrics  Journal of Nephrology & Therapeutics Journal of Nephrology & Therapeutics  Andrology & Gynecology: Current Research  Gynecology & Obstetrics  Journal of Nephrology & Therapeutics Journal of Nephrology & Therapeutics

15  2nd International Conference on Gynecology & Obstetrics 2nd International Conference on Gynecology & Obstetrics  3rd International Conference on Gastroenterology & Urology 3rd International Conference on Gastroenterology & Urology  2nd International Conference on Gynecology & Obstetrics 2nd International Conference on Gynecology & Obstetrics  3rd International Conference on Gastroenterology & Urology 3rd International Conference on Gastroenterology & Urology Gynecology & Obstetrics Related Conferences

16 OMICS Group Open Access Membership OMICS publishing Group Open Access Membership enables academic and research institutions, funders and corporations to actively encourage open access in scholarly communication and the dissemination of research published by their authors. For more details and benefits, click on the link below: OMICS publishing Group Open Access Membership enables academic and research institutions, funders and corporations to actively encourage open access in scholarly communication and the dissemination of research published by their authors. For more details and benefits, click on the link below:


Download ppt "OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and."

Similar presentations


Ads by Google